Thomas D Madden

This inventor holds 24 USPTO granted patents and 12 published patent applications, plus 17 CIPO patents and 6 EPO patents, primarily in Lipid Nanoparticle Technology. Top assignees: The Liposome Company, Inc., The University of British Columbia, Tekmira Pharmaceuticals Corporation. Active years: 1989-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas D Madden. Retrieved from https://idiyas.com/inventor/thomas-d-madden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 12)

% Patents Active = 87.5

CIPO Patents = 17 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.7

ph-index = 16

Forward Citations = 1,458(Granted Patents)

Company Filing History:

10 out of 115

The Liposome Company, Inc.

patents

6 out of 963

The University of British Columbia

patents

3 out of 14

Tekmira Pharmaceuticals Corporation

patents

4. 2 out of 28

Acuitas Therapeutics, Inc.

patents

5. 2 out of 3

Hana Biosciences, Inc.

patents

6. 2 out of 28

Inex Pharmaceuticals Corporation

patents

7. 1 out of 57

Arbutus Biopharma Corporation

patents

where one patent can have more than one assignee

Years Active: 1989-2025

Loading Chart...

Areas of Expertise:

Lipid Nanoparticle Formulations

Amino Lipids

Nucleic Acid Delivery

Liposomal Antineoplastic Drugs

Cancer Treatment

Drug-Lipid Complexes

Programmable Liposomes

Photodynamic Therapy

Dehydrated Liposomes

Polyanionic Polymers

Biocompatible Lipids

Encapsulation Techniques

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12491261 - Lipid nanoparticle formulations (2025-12-09),

2. 11712481 - Lipid nanoparticle formulations (2023-08-01),

3. 10653780 - Amino lipids and methods for the delivery of nucleic acids (2020-05-19),

4. 9139554 - Amino lipids and methods for the delivery of nucleic acids (2015-09-22),

5. 7811602 - Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof (2010-10-12),

6. 7452550 - Liposomal antineoplastic drugs and uses thereof (2008-11-18),

7. 7311924 - Compositions and methods for treating cancer (2007-12-25),

8. 7244448 - Liposomal antineoplastic drugs and uses thereof (2007-07-17),

9. 7060828 - Liposomal camptothecins and uses thereof (2006-06-13),

10. 6986902 - Polyanionic polymers which enhance fusogenicity (2006-01-17),

11. 6673364 - Liposome having an exchangeable component (2004-01-06),

12. 6406713 - Methods of preparing low-toxicity drug-lipid complexes (2002-06-18),

13. 5922350 - Methods of dehydrating, storing and rehydrating liposomes (1999-07-13),

14. 5885613 - Bilayer stabilizing components and their use in forming programmable (1999-03-23),

15. 5858397 - Liposomal formulations of mitoxantrone (1999-01-12),

Title: The Inventor Thomas D Madden: Revolutionizing Technology in Vancouver

Introduction: Thomas D Madden is a renowned inventor based in Vancouver, Canada, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Thomas D Madden holds several patents in various technological domains, including artificial intelligence, renewable energy, and sustainable transportation.

Career Highlights: With a career spanning over two decades, Thomas D Madden has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have significantly impacted the industry.

Collaborations: Throughout his career, Thomas D Madden has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative efforts have led to the successful implementation of several groundbreaking projects.

Conclusion: Thomas D Madden's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology in Vancouver and beyond.

Profile summary based on public USPTO records.